The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 22 results:
Author Title Type [ Year(Asc)]
Filters: Author is Goulis, Ioannis  [Clear All Filters]
2022
Oikonomou, I. Marios, Sinakos E., Antoniadis N., Goulis I., Giouleme O., Anifanti M., et al. (2022).  Effects of an active lifestyle on the physical frailty of liver transplant candidates.. World J Transplant. 12(11), 365-377.
Katsanos, G., Karakasi K-E., Antoniadis N., Vasileiadou S., Kofinas A., Morsi-Yeroyannis A., et al. (2022).  Enhanced recovery after surgery in liver transplantation: Challenges and feasibility.. World J Transplant. 12(7), 195-203.
2020
Protopapas, A. A., Papagiouvanni I., Fragkou N., Alevroudis E., Sinakos E., & Goulis I. (2020).  Estimation of glomerular filtration rate in patients with cirrhosis: evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate.. Eur J Gastroenterol Hepatol.
2019
Cholongitas, Ε., Koukoufiki A., Pipili C., Antoniadis N., Fouzas I., Haidich A-B., et al. (2019).  Is everolimus linked to metabolic syndrome in liver transplant recipients?. Indian J Gastroenterol. 38(4), 348-355.
2018
Pyrpasopoulou, A., Pitsava G., Iosifidis E., Imvrios G., Massa E., Mouloudi E., et al. (2018).  Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria.. J Infect. 77(5), 448-454.
Marshall, A. D., Cunningham E. B., Nielsen S., Aghemo A., Alho H., Backmund M., et al. (2018).  Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.. Lancet Gastroenterol Hepatol. 3(2), 125-133.
Soulaidopoulos, S., Cholongitas E., Giannakoulas G., Vlachou M., & Goulis I. (2018).  Review article: Update on current and emergent data on hepatopulmonary syndrome. World Journal of Gastroenterology. 24(12), 1285 - 1298.
Soulaidopoulos, S., Cholongitas E., Giannakoulas G., Vlachou M., & Goulis I. (2018).  Review article: Update on current and emergent data on hepatopulmonary syndrome.. World J Gastroenterol. 24(12), 1285-1298.
Doumtsis, P., Oikonomou T., Goulis I., Zachou K., Dalekos G., & Cholongitas E. (2018).  Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia.. Ann Gastroenterol. 31(1), 123-126.
Karkos, C. D., & Goulis I. (2018).  An Unusual Cause of Haematemesis.. Eur J Vasc Endovasc Surg. 55(5), 656.
2017
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Soulaidopoulos, S., Goulis I., Giannakoulas G., Panagiotidis T., Doumtsis P., Karasmani A., et al. (2017).  Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis.. Ann Gastroenterol. 30(2), 225-231.
Oikonomou, T., Goulis I., Soulaidopoulos S., Karasmani A., Doumtsis P., Tsioni K., et al. (2017).  High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis.. Ann Gastroenterol. 30(2), 217-224.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Cholongitas, E., Goulis I., Ioannidou M., Soulaidopoulos S., Chalevas P., & Akriviadis E. (2017).  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.. Hepatol Int. 11(3), 306-314.
2016
Sinakos, E., Antoniadis N., Goulis I., Cholongitas E., Kiapidou S., Tsakni E., et al. (2016).  Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.. Ann Gastroenterol. 29(2), 208-13.
Cholongitas, E., Antoniadis N., Goulis I., Fouzas I., Vasiliadis T., Akriviadis E., et al. (2016).  Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.. Liver Transpl. 22(1), 132-3.
2015
Goulis, I., Karatapanis S., Akriviadis E., Deutsch M., Dalekos G. N., Raptopoulou-Gigi M., et al. (2015).  On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients.. Liver Int. 35(5), 1540-8.
2014
Cholongitas, Ε., Goulis I., Theocharidou E., Antoniadis N., Fouzas I., Giakoustidis D., et al. (2014).  Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience.. Hepatol Int. 8(1), 137-45.
Cholongitas, E., Goulis I., Antoniadis N., Fouzas I., Imvrios G., Papanikolaou V., et al. (2014).  New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.. Transpl Int. 27(10), 1022-8.
2013
Pachiadakis, I., Choksi S., Ilonidis G., Akriviadis E., & Goulis I. (2013).  Letter to the editor concerning the paper: Boltjes A, Op den Brouw ML, Biesta PJ, et al. Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients [Molecular Immunolog. Mol Immunol. 56(1-2), 129-30.
2011
Imvrios, G., Vrochides D., Papanikolaou V., Fouzas I., Antoniadis N., Giakoustidis D., et al. (2011).  HCC influence on patient survival after liver transplantation for HDV cirrhosis.. Hepatogastroenterology. 58(110-111), 1654-8.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.